Matches in SemOpenAlex for { <https://semopenalex.org/work/W1503448416> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W1503448416 endingPage "3545" @default.
- W1503448416 startingPage "3538" @default.
- W1503448416 abstract "The promoters of the E-selectin, vascular cell adhesion molecule-1 (VCAM-1), and intercellular adhesion molecule-1 (ICAM-1) genes contain recognition sequences for the inducible nuclear transcription factor kappa B (NF-kappa B). We demonstrate that the appearance of NF-kappa B DNA-binding activity in the nucleus of TNF-alpha-stimulated HUVEC is associated with the rapid phosphorylation and subsequent degradation of I kappa B-alpha, the cytoplasmic inhibitor of NF-kappa B. Serine protease inhibitors prevented the TNF-alpha-induced accumulation of phosphorylated I kappa B-alpha, and prevented I kappa B-alpha degradation and the appearance of NF-kappa B DNA-binding activity. These inhibitors had no direct effect upon the ability of NF-kappa B to bind its cognate recognition sequences, nor upon the DNA-binding activities of other transcription factors. Inhibition of I kappa B-alpha proteolysis resulted in the inhibition of the cytokine- and LPS-induced transcriptional up-regulation and cell-surface expression of E-selectin, VCAM-1, and ICAM-1. In contrast, the TNF-alpha-induced expression of plasminogen activator inhibitor-1 and the constitutive expression of ICAM-2 were unaffected. These inhibitors also had no effect on cellular viability or rates of RNA or protein synthesis. Inhibitors of other proteases and various protein kinases had no effect on the cytokine-induced expression of these endothelial adhesion molecules. These findings indicate that it is possible, using a single pharmacologic agent, to selectively inhibit the expression of the E-selectin, VCAM-1, and ICAM-1 genes without affecting the constitutive or inducible expression of other genes. Pharmacologic inhibition of I kappa B-alpha proteolysis represents a novel approach to the development of anti-inflammatory therapeutics." @default.
- W1503448416 created "2016-06-24" @default.
- W1503448416 creator A5010807683 @default.
- W1503448416 creator A5060973233 @default.
- W1503448416 creator A5064994735 @default.
- W1503448416 creator A5084770352 @default.
- W1503448416 date "1995-10-01" @default.
- W1503448416 modified "2023-10-14" @default.
- W1503448416 title "Selective inhibition of E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 expression by inhibitors of I kappa B-alpha phosphorylation." @default.
- W1503448416 doi "https://doi.org/10.4049/jimmunol.155.7.3538" @default.
- W1503448416 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7561050" @default.
- W1503448416 hasPublicationYear "1995" @default.
- W1503448416 type Work @default.
- W1503448416 sameAs 1503448416 @default.
- W1503448416 citedByCount "148" @default.
- W1503448416 countsByYear W15034484162012 @default.
- W1503448416 countsByYear W15034484162013 @default.
- W1503448416 countsByYear W15034484162014 @default.
- W1503448416 countsByYear W15034484162015 @default.
- W1503448416 countsByYear W15034484162016 @default.
- W1503448416 countsByYear W15034484162017 @default.
- W1503448416 countsByYear W15034484162018 @default.
- W1503448416 countsByYear W15034484162022 @default.
- W1503448416 countsByYear W15034484162023 @default.
- W1503448416 crossrefType "journal-article" @default.
- W1503448416 hasAuthorship W1503448416A5010807683 @default.
- W1503448416 hasAuthorship W1503448416A5060973233 @default.
- W1503448416 hasAuthorship W1503448416A5064994735 @default.
- W1503448416 hasAuthorship W1503448416A5084770352 @default.
- W1503448416 hasBestOaLocation W15034484161 @default.
- W1503448416 hasConcept C1491633281 @default.
- W1503448416 hasConcept C153911025 @default.
- W1503448416 hasConcept C16224149 @default.
- W1503448416 hasConcept C185592680 @default.
- W1503448416 hasConcept C2909375385 @default.
- W1503448416 hasConcept C55493867 @default.
- W1503448416 hasConcept C85789140 @default.
- W1503448416 hasConcept C86803240 @default.
- W1503448416 hasConcept C95444343 @default.
- W1503448416 hasConceptScore W1503448416C1491633281 @default.
- W1503448416 hasConceptScore W1503448416C153911025 @default.
- W1503448416 hasConceptScore W1503448416C16224149 @default.
- W1503448416 hasConceptScore W1503448416C185592680 @default.
- W1503448416 hasConceptScore W1503448416C2909375385 @default.
- W1503448416 hasConceptScore W1503448416C55493867 @default.
- W1503448416 hasConceptScore W1503448416C85789140 @default.
- W1503448416 hasConceptScore W1503448416C86803240 @default.
- W1503448416 hasConceptScore W1503448416C95444343 @default.
- W1503448416 hasIssue "7" @default.
- W1503448416 hasLocation W15034484161 @default.
- W1503448416 hasLocation W15034484162 @default.
- W1503448416 hasOpenAccess W1503448416 @default.
- W1503448416 hasPrimaryLocation W15034484161 @default.
- W1503448416 hasRelatedWork W2022728886 @default.
- W1503448416 hasRelatedWork W2039522938 @default.
- W1503448416 hasRelatedWork W2039832770 @default.
- W1503448416 hasRelatedWork W2061818094 @default.
- W1503448416 hasRelatedWork W2071197381 @default.
- W1503448416 hasRelatedWork W2127961356 @default.
- W1503448416 hasRelatedWork W2136060822 @default.
- W1503448416 hasRelatedWork W2360724738 @default.
- W1503448416 hasRelatedWork W2770094165 @default.
- W1503448416 hasRelatedWork W3040820654 @default.
- W1503448416 hasVolume "155" @default.
- W1503448416 isParatext "false" @default.
- W1503448416 isRetracted "false" @default.
- W1503448416 magId "1503448416" @default.
- W1503448416 workType "article" @default.